Thomas Weisel Reinstates Coverage on Eclipsys (ECLP) with a Marketweight
ECLP Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Thomas Weisel reinstates coverage on Eclipsys (Nasdaq: ECLP) with a Marketweight rating.
To see all the upgrades/downgrades on shares of ECLP, visit our Analyst Ratings page.
Eclipsys Corporation (Eclipsys) is a provider of advanced integrated clinical, revenue cycle and performance management software, and professional services that help healthcare organizations improve clinical, financial and operational outcomes.
To see all the upgrades/downgrades on shares of ECLP, visit our Analyst Ratings page.
Eclipsys Corporation (Eclipsys) is a provider of advanced integrated clinical, revenue cycle and performance management software, and professional services that help healthcare organizations improve clinical, financial and operational outcomes.
You May Also Be Interested In
- UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
- UBS Maintains a 'Neutral' on VeriFone (PAY); Europe Demand Healthy, but FX Emerges as Headwind
- Piper Jaffray Starts Life Technologies (LIFE) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
Thomas Weisel Partners GroupSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
